<?xml version="1.0" encoding="UTF-8"?>
<document id="27903752">
	<sentence id="s1" text="Global gene expression profiling studies were carried out using cancer cells and surrogate tissues, such as whole blood and skin, to identify genes that are modulated by central nervous system development family proteins.">
		<entity id="s1.e1" charOffset="64-70"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="170-204"
			type="GO" text="central nervous system development" ontology_id="GO_0007417"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Candidate markers were further characterized for concentration- and time-dependent responses to the central nervous system development inhibitor ABBV-075 in vitro and in vivo negative regulation of transcription by RNA polymerase II was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.">
		<entity id="s2.e1" charOffset="100-134"
			type="GO" text="central nervous system development" ontology_id="GO_0007417"/>
		<entity id="s2.e2" charOffset="175-232"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s2.e3" charOffset="294-300"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Markers such as positive regulation of neuron projection development, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
		<entity id="s3.e1" charOffset="16-68"
			type="GO" text="positive regulation of neuron projection development" ontology_id="GO_0010976"/>
		<entity id="s3.e2" charOffset="70-88"
			type="GO" text="biological_process" ontology_id="GO_0008150"/>
		<entity id="s3.e3" charOffset="83-117"
			type="GO" text="central nervous system development" ontology_id="GO_0007417"/>
		<entity id="s3.e4" charOffset="94-131"
			type="GO" text="negative regulation of cell migration" ontology_id="GO_0030336"/>
		<entity id="s3.e5" charOffset="136-142"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e6" charOffset="168-174"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e3"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p3" e1="s3.e2"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p4" e1="s3.e4"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p5" e1="s3.e3"
		    e2="s3.e6" pgr="false"/>
		<pair id="s3.p6" e1="s3.e1"
		    e2="s3.e10" pgr="false"/>
		<pair id="s3.p7" e1="s3.e4"
		    e2="s3.e10" pgr="false"/>
		<pair id="s3.p8" e1="s3.e7"
		    e2="s3.e10" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Significant downregulation of negative regulation of transcription by RNA polymerase II, a well-publicized target of central nervous system development inhibitors, was largely restricted to hematologic cancer cell lines.">
		<entity id="s4.e1" charOffset="30-87"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s4.e2" charOffset="65-99"
			type="GO" text="central nervous system development" ontology_id="GO_0007417"/>
		<entity id="s4.e3" charOffset="150-156"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e3"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e3" pgr="true"/>
	</sentence>
</document>
